Work

CATALYST: A Phase 4 Study of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes Despite Receiving Standard-of-Care Therapies Assessing Prevalence and Treatment with Mifepristone

Year: 2023

Type: article

Study design: Study Protocol

Source: American Heart Journal

DOI: 10.1016/j.ahj.2023.08.047

Authors: Juan P. Frias, Richard J. Auchus, Irina Bancos, Lawrence Blonde, Robert S. Busch, John B. Buse, Ralph A. DeFronzo, Vivian Fonseca, Oksana Hamidi, Yehuda Handelsman, Richard E. Pratley, Julio Rosenstock, Iulia Cristina Tudor, Andreas G. Moraitis, Daniel Einhorn

Institutions: Velocity Clinical Research (United States), University of Michigan, Michigan Medicine, Mayo Clinic, Ochsner Health System, Ochsner Medical Center, Albany Medical College, University of North Carolina at Chapel Hill, The University of Texas at San Antonio Health Science Center, Tulane University, The University of Texas Southwestern Medical Center, AdventHealth Orlando, AdventHealth, Medical City Dallas Hospital, Corcept Therapeutics (United States)

Language: English

Topic: Adrenal Hormones and Disorders

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389469295

FWCI:

Cites:

Cited by:

Related to: 10